Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

David Piraino, MD

216.444.4845

David Piraino, MD

Appointed: 1985

David Piraino, MD
Department: Diagnostic Radiology
Imaging Informatics Officer
Location: Cleveland Clinic Main Campus
Mail Code A21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.4845
DeskDesk:216.444.4853
WorkFax:216.444.9307
David Piraino, MD
Department: Orthopaedic Surgery
Location: Cleveland Clinic Main Campus
Mail Code A21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.4845
DeskDesk:216.444.4853
WorkFax:216.444.9307
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

David Piraino, MD, is Head of the Section of Computers in Radiology of the Department of Diagnostic Radiology and is on Staff in the Department of Orthopedic Surgery at Cleveland Clinic, where he was appointed in 1985.

Dr. Piraino received his BS from Allegheny College in Meadville, Pa. He earned his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio. Dr. Piraino performed his radiology residency at Cleveland Clinic in Cleveland and completed a bone and joint fellowship at Vanderbilt University in Nashville, Tenn.

His specialty interests include magnetic resonance imaging, musculoskeletal radiology, three-dimensional image processing and imaging informatics.

Professional Highlights

  • Past Chairman, IHE Strategic Development Committee
  • Past Chairman, Radiology Information System Consortium

Education & Fellowships

Residency - Cleveland Clinic
Diagnostic Radiology
Cleveland, OH USA
1985
Fellowship - Vanderbilt University Medical Center
Radiology
Nashville, TN USA
1985
Medical School - Case Western Reserve University School of Medicine
Cleveland, OH USA
1981
Undergraduate - Allegheny College
Chemistry
Meadville, PA USA
1977

Certifications

  • Diagnostic Radiology

Specialty Interests

3D image processing, imaging informatics, musculoskeletal imaging

Awards & Honors

Fellow, Society of Imaging Informatics in Medicine

Innovations & Patents

  • U.S. Patent #5,517,990, Stereotaxy Wand and Tool Guide; IH Kalfas, DW Kormos, DW Piraino, GH Barnett; 1996
  • Japanese Patent #08052115, Method and Device to Position and Guide Equipment Application; IH Kalfas, DW Kormos, DW Piraino, GH Barnett; 1996
  • Japanese Patent #08238257, Stereo-Tactic System and Method, DW Kormos and DW Piraino; 1996
  • U.S. Patent #5,682,890, Magnetic Resonance Stereotactic Surgery with Exoskeleton Tissue Stabilization, DW Kormos and DW Piraino; 1997
  • U.S. Patent #5,732,703, Stereotaxy Wand and Tool Guide; IH Kalfas, DW Kormos, DW Piraino, GH Barnett, CP Steiner; 1998
  • U.S. Patent #5,776,064, Frameless Stereotaxy System for Indicating the Position and Axis of a Surgical Probe; IH Kalfas, DW Kormos, DW Piraino, GH Barnett, CP Steiner; 1998
  • European Patent #EP 0 676 178, Apparatus for Orienting and Guiding the Application of Tools; IH Kalfas, DW Piraino, DW Kormos, GH Barnett
  • European Patent #EP 0 728 446, Stereotaxy Systems; DW Kormos and DW Piraino; 2000

Memberships

  • Radiological Society of North America
  • American Roentgen Ray Society
  • Society of Imaging Informatics in Medicine

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/20/2014, Dr. Piraino has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Piraino receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • Mako Surgical Corp.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Piraino may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

  • Mako Surgical Corp.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English